SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
HK Stock Market Move | PLOVER BAY TECH (01523) rose more than 3%, proposing a spin-off and plans to list the spun-off entity on NASDAQ independently.
New Stocks Outlook | Scarcity in Profit Performance vs. Dependence on a Single Supplier, Can Green Cloud Software Tell the Story of the Hotel "Brain" Well?
HK Stock Market Move | Aviation stocks across the board are rising, with offshore yuan against the US dollar breaking through 6.85. The appreciation of the yuan is beneficial for airlines to release their performance.
HK Stock Market Move | PLOVER BAY TECH (01523) rose more than 3%, proposing a spin-off and plans to list the spun-off entity on NASDAQ independently.
New Stocks Outlook | Scarcity in Profit Performance vs. Dependence on a Single Supplier, Can Green Cloud Software Tell the Story of the Hotel "Brain" Well?
HK Stock Market Move | Aviation stocks across the board are rising, with offshore yuan against the US dollar breaking through 6.85. The appreciation of the yuan is beneficial for airlines to release their performance.
RECOMMEND
Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026
Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026
AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026
